𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn’s disease

✍ Scribed by Jean-Frédéric Colombel; Marc Lémann; Michel Cassagnou; Yoram Bouhnik; Bernard Duclos; Jean-Louis Dupas; Bertrand Notteghem; Jean-Yves Mary


Book ID
119396096
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
50 KB
Volume
94
Category
Article
ISSN
0002-9270

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A randomized, double-blind, placebo-cont
✍ J. P. Wright; Dr. D. P. Jewell; R. Modigliani; H. Malchow 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 486 KB 👁 2 views

Olsalazine, consisting of two salicylate radicals linked by an azo-bond, is effective in the treatment of active ulcerative colitis. To test its effect in patients with mild to moderate attacks of Crohn's disease, the International Organization for the Study of Inflammatory Bowel Disease (IOIBD) des